<div id="readability-page-1"><div><ul> <li>If you are wondering whether Sysmex shares are now priced attractively or still have further to fall, this article walks through what the current share price might be implying about the company's value.</li> <li>The stock last closed at ¥1,467, after a 9.6% move over the past 7 days, a modest 0.3% return over 30 days, and longer term returns of a 4.4% decline year to date, a 44.9% decline over 1 year, a 45.0% decline over 3 years, and a 58.1% decline over 5 years.</li> <li>Recent coverage around Sysmex has focused on its position in the healthcare sector and how investors are reassessing companies in this space, especially those with established products and global reach. This backdrop helps frame why the share price has shifted recently and why some investors are rechecking their assumptions about what a fair price looks like today.</li> <li>On our valuation checks, Sysmex currently scores 3 out of 6, meaning it screens as undervalued on half of the metrics we track. Next, we will look at what different valuation methods say about that score, before finishing with a more complete way to think about value that ties all of these pieces together.</li> </ul> <p>Find out why Sysmex's -44.9% return over the last year is lagging behind its peers.</p> <h3>Approach 1: Sysmex Discounted Cash Flow (DCF) Analysis</h3> <p>A Discounted Cash Flow, or DCF, model takes estimates of the cash a company may generate in future years and discounts those amounts back into today’s money to arrive at an estimated intrinsic value per share.</p> <p>For Sysmex, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections in ¥. The latest twelve month free cash flow is ¥27,423.60 million. Analyst estimates and subsequent extrapolations point to projected free cash flow of ¥50,425.75 million by the year ending March 2030, with a series of annual projections between now and 2035 that Simply Wall St has discounted back to today.</p> <p>When all of those projected cash flows are added and discounted, the model arrives at an estimated fair value of ¥1,567.57 per share. Compared with the recent market price of ¥1,467, the DCF output implies Sysmex trades at about a 6.4% discount to this estimate, which places it in the “roughly in line” bucket rather than looking extremely cheap or expensive.</p> <p><strong>Result: ABOUT RIGHT</strong></p> <p>Sysmex is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.</p> <figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4bfd7ddf-83f1-49f8-bedf-8070df38967e/chart/dcf/query-ZGF0ZT0yMDI2LTAyLTI3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4bfd7ddf-83f1-49f8-bedf-8070df38967e/chart/dcf/query-ZGF0ZT0yMDI2LTAyLTI3"/><figcaption>6869 Discounted Cash Flow as at Feb 2026</figcaption></figure> <p>Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Sysmex.</p> <h3>Approach 2: Sysmex Price vs Earnings</h3> <p>P/E is a useful way to think about valuation for profitable companies because it directly links what you pay for each share to the earnings that support that share. When investors expect stronger growth or see lower risk, they are usually willing to accept a higher P/E, while slower growth or higher risk tends to justify a lower P/E.</p> <p>Sysmex currently trades on a P/E of 20.4x. That is close to the Medical Equipment industry average of 15.5x and very similar to the peer average of 20.5x, so on simple comparisons the stock looks roughly in line with similar names rather than clearly cheap or expensive.</p> <p>Simply Wall St’s Fair Ratio is a proprietary estimate of what P/E might make sense for Sysmex given its earnings growth profile, industry, profit margins, market cap and risk factors. This is more tailored than a straight peer or industry comparison because those benchmarks do not adjust for company specific strengths or weaknesses. For Sysmex, the Fair Ratio is 26.6x, which is higher than the current 20.4x P/E, suggesting the shares trade below this estimate of fair value.</p> <p><strong>Result: UNDERVALUED</strong></p> <figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4bfd7ddf-83f1-49f8-bedf-8070df38967e/chart/pe-multiple-vs-industry/query-ZGF0ZT0yMDI2LTAyLTI3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4bfd7ddf-83f1-49f8-bedf-8070df38967e/chart/pe-multiple-vs-industry/query-ZGF0ZT0yMDI2LTAyLTI3"/><figcaption>TSE:6869 P/E Ratio as at Feb 2026</figcaption></figure> <p>P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 12 top founder-led companies.</p> <h3>Upgrade Your Decision Making: Choose your Sysmex Narrative</h3> <p>Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, a simple way to attach your own story about Sysmex to the numbers behind its fair value, revenue, earnings and margins.</p> <p>A Narrative is your view of what the company is doing, where it might be heading and how that could show up in future financials, all pulled together into one clear forecast and an implied fair value per share.</p> <p>On Simply Wall St, Narratives live in the Community page, where millions of investors can create and share these story driven forecasts, then compare their Fair Value to the current share price to help them decide how Sysmex fits into their portfolio.</p> <p>Because Narratives are refreshed when new information arrives, such as earnings updates or news, your fair value view can shift automatically. You will often see very different takes on Sysmex. For example, one Narrative might assume a much higher fair value than today’s price, while another assumes a much lower one, reflecting different expectations for its future.</p> <p>Do you think there's more to the story for Sysmex? Head over to our Community to see what others are saying!</p> <figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4bfd7ddf-83f1-49f8-bedf-8070df38967e/chart/quote-price/query-ZGF0ZT0yMDI2LTAyLTI3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4bfd7ddf-83f1-49f8-bedf-8070df38967e/chart/quote-price/query-ZGF0ZT0yMDI2LTAyLTI3"/><figcaption>TSE:6869 1-Year Stock Price Chart</figcaption></figure> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data     and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your     financial situation. We aim to bring you long-term focused analysis driven by fundamental data.     Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.     Simply Wall St has no position in any stocks mentioned.</em></p><div><h3><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>• Connect an unlimited number of Portfolios and see your total in one currency<br/>• Be alerted to new Warning Signs or Risks via email or mobile<br/>• Track the Fair Value of your stocks<br/></p><p>Try a Demo Portfolio for Free</p></div></div></div>

6869

<p>Sysmex (TSE:6869) shares have seen a significant decline of 44.9% over the past year, closing at ¥1,467. A Discounted Cash Flow analysis suggests the stock is fairly valued at ¥1,567.57, indicating a 6.4% discount. The current P/E ratio of 20.4x is in line with industry averages, but below the estimated fair P/E of 26.6x, suggesting it may be undervalued. Investors are reassessing Sysmex's value amidst changes in the healthcare sector, prompting a closer look at its financial metrics and future projections.</p>

Is Sysmex (TSE:6869) Now Fairly Priced After A 45% One Year Share Price Slide?